Services: Non-Clinical

The Cato Research Nonclinical Safety Development team was created in 1998 and has since expanded the company's capabilities in terms of pharmacology and toxicology expertise and services. Our team of experts has a diverse background in regulatory toxicology and pharmacology from various pharmaceutical and biotechnology companies and contract research organizations (CROs). This combination of scientific, technical, and compliance expertise allows us to specialize in the design of nonclinical development program strategies that meet regulatory agency requirements in the most cost-effective and time-efficient manner.

We offer full nonclinical safety development services, which includes product development strategies, nonclinical safety study design and monitoring, data interpretation, and regulatory meetings and submissions support.